Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

Authors: John C. Araujo, Géralyn C. Trudel, Fred Saad, Andrew J. Armstrong, Evan Y. Yu, Joaquim Bellmunt, George Wilding, John McCaffrey, Sérgio Serrano, В. Б. Матвеев, Eleni Efstathiou, Stéphane Oudard, Michael J. Morris, Bruce Sizer, Peter J. Goebell, Axel Heidenreich, Johann S. de Bono, Stephen Begbie, Jun Hyuk Hong, Eduardo Richardet, Enrique Gallardo, Prashni Paliwal, S DURHAM, Shinta Cheng, Christopher J. Logothetis - The Lancet 2013 cited by 231